...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Biotech Showcase

Scheduled presentations are now listed on the Biotech Showcase website. Thanks in advance to noretreat (and others?) who may be attending.

Resverlogix Monday January 7, 4 PM Pacific

Zenith Epigenetics Tuesday January 8th, 9:15 AM Pacific

Share
New Message
Please login to post a reply